These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27569526)

  • 1. Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach.
    Koutsouleris N; Kahn RS; Chekroud AM; Leucht S; Falkai P; Wobrock T; Derks EM; Fleischhacker WW; Hasan A
    Lancet Psychiatry; 2016 Oct; 3(10):935-946. PubMed ID: 27569526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of multivariable prediction models of remission, recovery, and quality of life outcomes in people with first episode psychosis: a machine learning approach.
    Leighton SP; Upthegrove R; Krishnadas R; Benros ME; Broome MR; Gkoutos GV; Liddle PF; Singh SP; Everard L; Jones PB; Fowler D; Sharma V; Freemantle N; Christensen RHB; Albert N; Nordentoft M; Schwannauer M; Cavanagh J; Gumley AI; Birchwood M; Mallikarjun PK
    Lancet Digit Health; 2019 Oct; 1(6):e261-e270. PubMed ID: 33323250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction Tool for Individual Outcome Trajectories Across the Next Year in First-Episode Psychosis in Coordinated Specialty Care.
    Basaraba CN; Scodes JM; Dambreville R; Radigan M; Dachepally P; Gu G; Wang R; Dixon LB; Wall MM
    JAMA Psychiatry; 2023 Jan; 80(1):49-56. PubMed ID: 36322062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.
    Soldatos RF; Cearns M; Nielsen MØ; Kollias C; Xenaki LA; Stefanatou P; Ralli I; Dimitrakopoulos S; Hatzimanolis A; Kosteletos I; Vlachos II; Selakovic M; Foteli S; Nianiakas N; Mantonakis L; Triantafyllou TF; Ntigridaki A; Ermiliou V; Voulgaraki M; Psarra E; Sørensen ME; Bojesen KB; Tangmose K; Sigvard AM; Ambrosen KS; Meritt T; Syeda W; Glenthøj BY; Koutsouleris N; Pantelis C; Ebdrup BH; Stefanis N
    Schizophr Bull; 2022 Jan; 48(1):122-133. PubMed ID: 34535800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting one-year outcome in first episode psychosis using machine learning.
    Leighton SP; Krishnadas R; Chung K; Blair A; Brown S; Clark S; Sowerbutts K; Schwannauer M; Cavanagh J; Gumley AI
    PLoS One; 2019; 14(3):e0212846. PubMed ID: 30845268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach.
    de Nijs J; Burger TJ; Janssen RJ; Kia SM; van Opstal DPJ; de Koning MB; de Haan L; ; Cahn W; Schnack HG
    NPJ Schizophr; 2021 Jul; 7(1):34. PubMed ID: 34215752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
    Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
    Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.
    Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E;
    JAMA Psychiatry; 2021 Feb; 78(2):195-209. PubMed ID: 33263726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).
    Boter H; Peuskens J; Libiger J; Fleischhacker WW; Davidson M; Galderisi S; Kahn RS;
    Schizophr Res; 2009 Dec; 115(2-3):97-103. PubMed ID: 19819114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
    Volavka J; Czobor P; Derks EM; Bitter I; Libiger J; Kahn RS; Fleischhacker WW;
    J Clin Psychiatry; 2011 Jul; 72(7):955-61. PubMed ID: 21824456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.
    Koutsouleris N; Kambeitz-Ilankovic L; Ruhrmann S; Rosen M; Ruef A; Dwyer DB; Paolini M; Chisholm K; Kambeitz J; Haidl T; Schmidt A; Gillam J; Schultze-Lutter F; Falkai P; Reiser M; Riecher-Rössler A; Upthegrove R; Hietala J; Salokangas RKR; Pantelis C; Meisenzahl E; Wood SJ; Beque D; Brambilla P; Borgwardt S;
    JAMA Psychiatry; 2018 Nov; 75(11):1156-1172. PubMed ID: 30267047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
    Rasmussen SA; Rosebush PI; Anglin RE; Mazurek MF
    Psychiatry Res; 2016 Jul; 241():72-7. PubMed ID: 27156027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study.
    Peña J; Segarra R; Ojeda N; García J; Eguiluz JI; Gutiérrez M
    J Psychiatr Res; 2012 Jun; 46(6):774-81. PubMed ID: 22487311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Machine Learning-Based Model of Mortality Risk in First-Episode Psychosis.
    Lieslehto J; Tiihonen J; Lähteenvuo M; Leucht S; Correll CU; Mittendorfer-Rutz E; Tanskanen A; Taipale H
    JAMA Netw Open; 2024 Mar; 7(3):e240640. PubMed ID: 38497965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach.
    Haining K; Brunner G; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Schizophr Res; 2021 May; 231():24-31. PubMed ID: 33744682
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.